Croda International Plc, Corbion, and DSM are Dominating the Global Omega-3 Ingredients for Pharmaceuticals Market in 2019

Global Omega-3 Ingredients For Pharmaceuticals Market is expected to grow with the CAGR of 11.0% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access full Report @https://www.databridgemarketresearch.com/reports/global-omega-3-ingredients-for-pharmaceuticals-market

Global omega-3 ingredients for pharmaceuticals market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario. 

The major players dealing in global omega-3 ingredients for pharmaceuticals market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

• In March 2019, Corbion went under partnership with Sammy Monsour, a celebrity chef and sustainable seafood advocate in order to create awareness about the impact of algae-fed salmon on sustainable aquaculture and the global food system with consumers and the culinary community. This partnership by Corbion increased its credibility in the market with increased awareness of algae based products among consumers.

Croda International Plc is the dominating player in global omega-3 ingredients for pharmaceuticals market. The other key players existing in the market includes Avestia Pharma, Novasep, AbbVie Inc., KD Pharma Group, BASF SE, Corbion NV, DSM, AstraZeneca, GlaxoSmithKline plc., Fresenius Kabi AG, AMARIN CORPORATION, ANI Pharmaceuticals, Inc., Epax, Strides Pharma Science Limited, Pharma Marine AS, KinOmega Biopharm Inc., Camber Pharmaceuticals, Inc., Solutex, BASF SE among others.

Croda International Plc

Croda International Plc headquartered in East Yorkshire, U.K. The company is engaged in manufacturing and distribution of speciality chemicals that deliver real benefits to a range of diverse products including health and beauty, engine lubricants, plastics among others. The company has multiple business segments including personal care, life sciences, performance technologies, industrial chemicals, in these life sciences is the market focussed segment. The company has wide product portfolio such as adhesives, agrochemicals, automotive & transport, beauty & personal care, buildings & construction, dietary supplements, electronics & devices, energy, resources & renewables, food ingredients, furniture & wood, household industrial & institutional cleaning, lubricants, oleochemicals, packaging, print & paper, paints & coatings, pharmaceuticals, phase change & thermal management, polymers & additives, skin health, textiles, nonwovens & tissues, water treatment, in which dietary supplements is the market focused category.

• In May 2019, Croda International Plc has been working together on the innovation and development for the Open Innovation Programme with PhD scholar in research plan. The company has increased its global sale along with profit for the company.

The company has wide presence across Europe, North America, Latin America, Asia-Pacific. The company also has various subsidiary companies such as Brookstone Chemicals Limited (U.K.), Croda China Trading Company Ltd (China), Croda Chocques SAS (France), Croda EU BV (The Netherlands), Croda Nordica AB (Sweden), The Representative Office of Croda Singapore Pte Ltd (Vietnam) among others.

Corbion

Corbion headquartered in Amsterdam, the Netherlands, was founded in 1903. The company focuses on manufacturing of lactic acid, lactic acid derivatives, along with emulsifiers, functional enzyme blends, minerals, vitamins and algae ingredients. The company has wide product portfolio including food, biochemicals, biomedical, bioplastics in which food is the market focused categories.

• In June 2019, Corbion underwent exclusive global partnership with Lubrizol Corporation in order to bring AlgaPur, high stability high oleic algae oil to the personal care and cosmetics markets. This collaboration has increased the credibility of Corbion products in the market leading to increased sales in future.

The company has wide presence across North America, South America, Europe, Middle East and Africa and Asia-Pacific. The company also has various subsidiary companies such as Purac biochem BV (Netherlands), Succinity Gmbh (Germany), CSM (United Kingdom) Limited (U.K.), Purac China (China) and Granotec do Brazil (Brazil) among others.

DSM

DSM headquartered in Heerlen, the Netherlands was founded in 1902. The company focuses on specializing in nutrition, health and sustainable living in order to create better lives for all by manufacturing and distribution of solutions related to nutrition and health solutions, climate & energy solutions, resources and circulatory solutions among more. The company is engaged in providing wide range of product categories such as animal nutrition & health, human nutrition & health, personal care & aroma ingredients, pharmaceuticals, food specialties, engineering materials, coating resins, protective materials, additive manufacturing, biomedical, advanced solar, bio-based products & services in which human nutrition & health is the market focused product categories.

• In November 2019, DSM acquired AVA, the U.S. based personalized nutrition platform that offers nutrition and coaching recommendations across the wide range of health and wellness segments. This acquisition by DSM strengthens its human nutrition business thereby, increasing its demand in the market.

The company is present in North America, South America, Europe, Middle East and Africa and Asia-Pacific. The company has several owned subsidiaries involving Glycom A/S (Denmark), Fortitech, inc. (U.S.), Martek Biosciences Corporation (U.S.), Aland (Jiangsu) Nutraceutical Co., Ltd. (China) and Koninklijke CSK Food Enrichment C.V. (Netherlands) among others.